Published in Medical Letter on the CDC and FDA, March 28th, 2004
Earlier this month, Lupin received approval for its Cefixime Tablet 400 mg ANDA.
Lupin is the first company with an ANDA approval for Cefixime. Cefixime was marketed by Wyeth until March 2003 under the Suprax brand. Lupin will relaunch the product under the Suprax trademark that Lupin has licensed on an exclusive basis for the U.S. market.
Lupin Chairman Dr. Desh Bandhu Gupta said, "The approval of this important product marks Lupin's entry...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.